Vanguard Group Inc Sc Pharmaceuticals Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,369,836 shares of SCPH stock, worth $5.96 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,369,836
Previous 1,369,888
0.0%
Holding current value
$5.96 Million
Previous $8.59 Million
19.94%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SCPH
# of Institutions
80Shares Held
26.6MCall Options Held
101KPut Options Held
13.9K-
Orbimed Advisors LLC San Diego, CA5.56MShares$24.2 Million0.63% of portfolio
-
Rubric Capital Management LP New York, NY3.53MShares$15.3 Million0.6% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.39MShares$14.7 Million6.86% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$7.84 Million0.0% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX1.45MShares$6.32 Million0.03% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $119M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...